Skip to content
The COVID summer surge roundup
The U.S. is officially in the midst of another summer COVID surge as wastewater levels continue to peak for the second week, with no […]
The COVID summer surge roundup Read More »
New report highlights vaccine innovation, need for investment
A new report is not only a ringing endorsement of vaccine innovation but also a call for more investment in the vaccine pipeline. The
New report highlights vaccine innovation, need for investment Read More »
Another reason to get your flu shot? It can reduce your risk of heart attack
Researchers in the Netherlands have reaffirmed the link between influenza infections and the increased, short-term risk of heart attack. The risk is especially elevated
Another reason to get your flu shot? It can reduce your risk of heart attack Read More »
AMR infections increased 20% during COVID-19 – and continue to pose a threat
Antimicrobial resistance (AMR) presents a clear threat to human health and healthcare systems. And in the post-COVID era, the threat and calls to address
AMR infections increased 20% during COVID-19 – and continue to pose a threat Read More »
Exclusive: Sen. Burr on the legacy of Project BioShield and the urgency of PAHPA reauthorization
2001 was the dawn of the modern era of biosecurity in the United States. Following the 9/11 attacks and deadly anthrax letters, the nation
3 key priorities shaping the future of U.S. healthcare and biotech
A few topics keep popping up in discussions about the future of U.S. healthcare over the past couple of years. The need to pass
3 key priorities shaping the future of U.S. healthcare and biotech Read More »
Boehringer Ingelheim biomass plant cuts drug maker’s carbon footprint
Biopharma Boehringer Ingelheim took a big step toward achieving the company’s goal of carbon neutrality by 2030 with the July 8 inauguration of a
Boehringer Ingelheim biomass plant cuts drug maker’s carbon footprint Read More »
NIH Innovation Zone 2024: Talus Bio pioneers breakthroughs in ‘undruggable’ transcription factors
Talus Bio’s collaborative and innovative approach to unlocking the therapeutic potential of targeting transcription factors for cancer and other diseases is putting them at
Pride Month 2024: LGBTQ+ biotech leaders celebrate progress, recognize gaps
As 2024 Pride Month concludes, the biotech industry reflects on the critical importance of LGBTQ+ representation and the ongoing efforts to foster inclusivity. The
Pride Month 2024: LGBTQ+ biotech leaders celebrate progress, recognize gaps Read More »
NIH Innovation Zone 2024: Pirouette Medical is innovating safer, easier auto-injections
Injecting medicine can be a scary prospect. It is not just the fear of needles that can prevent patients from self-administration. Even traditional auto-injector
NIH Innovation Zone 2024: Pirouette Medical is innovating safer, easier auto-injections Read More »